Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

893 recalls · Class II, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 20262025202420232022 2017 All years
Cause Sterility / contaminationNitrosamine impurityChemical / undeclaredParticulate / foreign matterLabeling / mix-upcGMP deviationMicrobial contamination All causes
Class II · Moderate risk

Human Chorionic Gonadotropin 20

Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.

Terminated Labeling / mix-up KRS Global Biotechnology, Inc D-0178-2018
Class II · Moderate risk

Human Chorionic Gonadotropin 11

Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.

Terminated Labeling / mix-up KRS Global Biotechnology, Inc D-0177-2018
Class II · Moderate risk

Human Chorionic Gonadotropin 6

Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.

Terminated Labeling / mix-up KRS Global Biotechnology, Inc D-0176-2018
Class II · Moderate risk

Human Chorionic Gonadotropin 5

Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.

Terminated Labeling / mix-up KRS Global Biotechnology, Inc D-0175-2018
Class II · Moderate risk

Human Chorionic Gonadotropin 2

Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.

Terminated Labeling / mix-up KRS Global Biotechnology, Inc D-0174-2018
Class II · Moderate risk

Estriol 0.1%

Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.

Terminated Labeling / mix-up KRS Global Biotechnology, Inc D-0172-2018
Class II · Moderate risk

Bi-Est (Estriol/Estradiol)

Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.

Terminated Labeling / mix-up KRS Global Biotechnology, Inc D-0168-2018
Class II · Moderate risk

Benzocaine 20%

Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.

Terminated Labeling / mix-up KRS Global Biotechnology, Inc D-0166-2018
Class II · Moderate risk

Benzocaine 20%

Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.

Terminated Labeling / mix-up KRS Global Biotechnology, Inc D-0165-2018
Class II · Moderate risk

Anastrozole SR 1 mg Capsules

Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.

Terminated Labeling / mix-up KRS Global Biotechnology, Inc D-0163-2018
Class II · Moderate risk

Anastrozole 0.5 mg Capsules

Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.

Terminated Labeling / mix-up KRS Global Biotechnology, Inc D-0161-2018
Class II · Moderate risk

Clozapine Tablets USP

Failed Tablet/Capsule Specifications; potential presence of broken tablets.

Terminated Failed specification Teva Pharmaceuticals USA NDC 00093-7772-05 D-0096-2018

Recalls by year